Status | Study |
Recruiting |
Study Name: Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery Condition: Epithelioid Hemangioendothelioma Date: 2017-05-01 Interventions: Other: Laboratory Biomarker Analysis |
Enrolling by invitation |
Study Name: Clinical Evaluation of the Treatment of Spider Angioma Condition: Spider Angioma Date: 2016-04-25 Interventions: Device: KTP laser Dual Wavelength Laser Emitting 532 nm Laser Energy |
Recruiting |
Study Name: Pilot Trial of Type I-Polarized Autologous Dendritic Cell Vaccine Incorporating Tumor Blood Vessel Antigen-Derived Peptides in Patients With Metastatic Breast Cancer Condition: Breast Cancer Metastatic Breast Cancer Date: 2015-06-19 Interventions: Biological: tumor blood vessel antigen peptide-pulsed alpha-type-1 polarized |
Enrolling by invitation |
Study Name: Clinical Characteristics of Lip Hemangiomas Condition: Hemangioma Date: 2015-01-19 Interventions: Other: observation |
Recruiting |
Study Name: CyberKnife Based Hypofractionated Radiotherapy for Vertebral Hemangiomas Condition: Hemangioma of Vertebral Column Date: 2015-01-04 Interventions: Radiation: Cybernetic microradiosurgery |
Completed |
Study Name: Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors Condition: PEComa Hemangioma Date: 2014-12-22 Interventions: Other: Biopsy |
Recruiting |
Study Name: A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors Condition: Kaposiform Hemangioendothelioma (KHE) Kasabach-Merritt Syndrome Date: 2014-04-08 Interventions: Drug: Vincristine Vincristine |
Recruiting |
Study Name: Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma Condition: Adult Angiosarcoma Recurrent Adult Soft Tissue Sarcoma Sta Date: 2014-01-22 Interventions: Drug: regorafenib Given PO Other Names: |
Completed |
Study Name: The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma Condition: Hemangioma Date: 2013-07-09 Interventions: Drug: Prednisolone 2mg/kg/day |
Recruiting |
Study Name: Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma Condition: Metastatic Melanoma Date: 2013-06-10 Interventions: Biological: DC vaccine Other N |